Cytonex Sdn. Bhd. is a Malaysia-based BioNexus-status stem cell and regenerative medicine company focused on research, development, and commercialisation of advanced cellular therapeutics and regenerative biologics. As the parent R&D company, Cytonex drives scientific innovation, translational research, and patented technology advancement in regenerative healthcare.
Celbridge Sdn. Bhd. is a wholly owned subsidiary of Cytonex, with Stem Cell Therapy Asia serving as its marketing arm. Our product brands—Cytonext, NathPlus, and Byofit—support regenerative health, natural healing, and therapeutic innovation from laboratory to clinical application.
For years, stem cell therapy has been associated with one powerful idea: replacing damaged cells with healthy new ones. But recent regenerative medicine research…
Type 1 diabetes treatment has improved dramatically over recent decades, but insulin therapy still cannot fully recreate how the pancreas naturally regulates blood sugar. Researchers are now exploring..
Stories about paralysis recovery after stem cell treatment often generate excitement — but understanding the science behind those headlines matters. Recent studies are exploring whether stem cells…
MSC-derived exosomes verified by Nanoverify
(MOSTI-endorsed)
Cytonex delivers scientifically validated regenerative solutions, advanced stem cell technology and exosome innovation backed by regulatory recognition and quality assurance.
Our multidisciplinary team combines over decades of research and clinical expertise in stem cell technology, exosome development, and regenerative healthcare innovation.
Shoba Murugasu
Dr Taufiq Thiagi
Khairul Akmal
Dr. Norlaily Ali
Pavithra Dewi
Nurul Syahirah
Salehuddin Asyraf
Alia Sabrina
Janecenta Kaur
Najian Ibrahim
Our laboratory is equipped with advanced technology and strict quality-controlled processes to support stem cell and exosome research and development, and regenerative medicine innovation.
Our ongoing research and development efforts focus on advancing stem cell and exosome technologies to create safe, effective regenerative solutions that improve health outcomes and support the future of medicine.
Our network of medical specialists and research institutions supports stem cell therapy services and regenerative medicine research through trusted clinical and academic collaboration.
Join leading research institutions and healthcare organizations worldwide in advancing the future of medicine.
